You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-E Cadherin antibody [HECD-1], prediluted (ab1417)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-E Cadherin antibody [HECD-1], prediluted
See all E Cadherin products (24) ...

Description

Mouse monoclonal [HECD-1] to E Cadherin, prediluted

Tested applications

IHC-P, IHC-Frmore details

Cross reactivity

Reacts with

Human

Immunogen

Breast tumor cell line MCF-7

Positive control

Breast Cancer

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Storage buffer

Preservative: Proprietary, not sodium azide or thimerosal.
Constituents: PBS, Tissue Culture Supernatant. pH 7.3; Protein carrier.

Concentration

Concentration information loading...

Clonality

Monoclonal

Clone number

HECD-1

Myeloma

unknown

Isotype

IgG1

Light chain type

unknown

Applications

Show applications key

Our Abpromise guarantee covers the use of ab1417 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • IHC-P

     
  • IHC-Fr

     

Application notes

IHC:
This antibody is pre-diluted for use with an ABC system.
For formalin fixed paraffin embedded sections, perform heat mediated antigen retrieval before commencing with IHC.

Target

Function

Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. CDH1 is involved in mechanisms regulating cell-cell adhesions, mobility and proliferation of epithelial cells. Has a potent invasive suppressor role. It is a ligand for integrin alpha-E/beta-7.
E-Cad/CTF2 promotes non-amyloidogenic degradation of Abeta precursors. Has a strong inhibitory effect on APP C99 and C83 production.

Tissue specificity

Non-neural epithelial tissues.

Involvement in disease

Defects in CDH1 are the cause of hereditary diffuse gastric cancer (HDGC) [MIM:137215]. An autosomal dominant cancer predisposition syndrome with increased susceptibility to diffuse gastric cancer. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. Note=Heterozygous germline mutations CDH1 are responsible for familial cases of diffuse gastric cancer. Somatic mutations in the has also been found in patients with sporadic diffuse gastric cancer and lobular breast cancer.
Defects in CDH1 are a cause of susceptibility to endometrial cancer (ENDMC) [MIM:608089].
Defects in CDH1 are a cause of susceptibility to ovarian cancer (OC) [MIM:167000]. Ovarian cancer common malignancy originating from ovarian tissue. Although many histologic types of ovarian neoplasms have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.

Sequence similarities

Contains 5 cadherin domains.

Post-translational
modifications

During apoptosis or with calcium influx, cleaved by a membrane-bound metalloproteinase (ADAM10), PS1/gamma-secretase and caspase-3 to produce fragments of about 38 kDa (E-CAD/CTF1), 33 kDa (E-CAD/CTF2) and 29 kDa (E-CAD/CTF3), respectively. Processing by the metalloproteinase, induced by calcium influx, causes disruption of cell-cell adhesion and the subsequent release of beta-catenin into the cytoplasm. The residual membrane-tethered cleavage product is rapidly degraded via an intracellular proteolytic pathway. Cleavage by caspase-3 releases the cytoplasmic tail resulting in disintegration of the actin microfilament system. The gamma-secretase-mediated cleavage promotes disassembly of adherens junctions.

Cellular localization

Cell junction. Cell membrane. Endosome. Golgi apparatus > trans-Golgi network. Colocalizes with DLGAP5 at sites of cell-cell contact in intestinal epithelial cells. Anchored to actin microfilaments through association with alpha-, beta- and gamma-catenin. Sequential proteolysis induced by apoptosis or calcium influx, results in translocation from sites of cell-cell contact to the cytoplasm. Colocalizes with RAB11A endosomes during its transport from the Golgi apparatus to the plasma membrane.

Target information above from: UniProt accessionP12830 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Arc 1 antibody
  • CADH1_HUMAN antibody
  • Cadherin 1 antibody
  • cadherin 1 type 1 E-cadherin antibody
  • Cadherin1 antibody
  • CAM 120/80 antibody
  • CD 234 antibody
  • CD324 antibody
  • CD324 antigen antibody
  • CDH1 antibody
  • CDHE antibody
  • E-Cad/CTF3 antibody
  • E-cadherin antibody
  • ECAD antibody
  • Epithelial cadherin antibody
  • epithelial calcium dependant adhesion protein antibody
  • LCAM antibody
  • Liver cell adhesion molecule antibody
  • UVO antibody
  • Uvomorulin antibody
see all

References for Anti-E Cadherin antibody [HECD-1], prediluted (ab1417)

ab1417 has not yet been referenced specifically in any publications.

Publishing research using ab1417? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"